c="Osteogenesis imperfecta" 1:0 1:1||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
c="frameshift mutation" 1:11 1:12||t="problem"||cui="C0079380"||tot="Frameshift Mutation function"||ns="-1000"
c="Osteogenesis imperfecta (OI" 2:0 2:2||t="problem"||cui="C0029434"||tot="Osteogenesis Imperfecta"||ns="-1000"
c="brittle-bone disorder" 2:4 2:5||t="problem"||cui="C1859069"||tot="BRITTLE BONE DISORDER"||ns="-1000"
c="autosomal recessive form" 2:22 2:24||t="treatment"||cui="C0013058"||tot="Dosage Form"||ns="-827"
c="nuclease S1 mapping" 2:45 2:47||t="medication"||cui="C1283195"||tot="Mapping - action"||ns="-827"
c="Polyacrylamide gel electrophoresis" 2:100 2:102||t="test"||cui="C0013862"||tot="Polyacrylamide Gel Electrophoresis"||ns="-1000"
c="small homozygous deletion" 2:109 2:111||t="problem"||cui="C1442161"||tot="Gene Deletion Abnormality"||ns="-827"
c="four nucleotide frameshift deletion" 2:136 2:139||t="problem"||cui="C1442161"||tot="Gene Deletion Abnormality"||ns="-812"
